{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:59:20Z","timestamp":1769605160406,"version":"3.49.0"},"reference-count":47,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T00:00:00Z","timestamp":1312761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2011,11]]},"abstract":"<jats:p><jats:italic>Oral Diseases<\/jats:italic> (2011) <jats:bold>17<\/jats:bold>, 794\u2013800<\/jats:p><jats:p><jats:bold>Objectives:\u2002<\/jats:bold> Recent studies indicate various molecular abnormalities in oral squamous cell carcinomas (<jats:italic>OSCC<\/jats:italic>), including DNA methylation of tumor\u2010associated genes. Although promoter hypermethylation of <jats:italic>Wnt<\/jats:italic> pathway antagonists <jats:italic>RUNX3<\/jats:italic> (<jats:italic>Runt\u2010related transcription factor 3<\/jats:italic>) and <jats:italic>Wnt inhibitory factor 1<\/jats:italic> (<jats:italic>WIF1<\/jats:italic>) has been identified as a common event in a number of carcinomas, methylation status and the role <jats:italic>of RUNX3<\/jats:italic> as a possible tumor suppressor in oral and head and neck cancer are yet controversial. The aim of our study is to determine the occurrence of <jats:italic>RUNX3<\/jats:italic> and <jats:italic>WIF1<\/jats:italic> genes hypermethylation and correlation with tumor and host\u2010related factors and prognosis in tongue carcinomas.<\/jats:p><jats:p><jats:bold>Material and Methods:\u2002<\/jats:bold> In 76 patients with tongue carcinoma, <jats:italic>RUNX3<\/jats:italic> and <jats:italic>WIF1<\/jats:italic> genes promoter hypermethylation analysis was assessed by nested methylation\u2010specific PCR method.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Hypermethylation of <jats:italic>WIF1<\/jats:italic> and <jats:italic>RUNX3<\/jats:italic> genes promoters was observed in 35% and 25% of carcinomas, respectively. <jats:italic>RUNX3<\/jats:italic> gene promoter hypermethylation was significantly associated with lymph node involvement (<jats:italic>P<\/jats:italic>\u2003=\u20030.013) and tumor stage (<jats:italic>P<\/jats:italic>\u2003=\u20030.006), but not with the overall survival. Occurrence of <jats:italic>RUNX3<\/jats:italic> and <jats:italic>WIF1<\/jats:italic> genes comethylation was associated with nodal status (<jats:italic>P<\/jats:italic>\u2003= 0.058) and tumor stage (<jats:italic>P<\/jats:italic>\u2003=\u20030.055).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Our findings indicate that <jats:italic>RUNX3<\/jats:italic> and <jats:italic>WIF1<\/jats:italic> are frequently aberrantly methylated and that <jats:italic>RUNX3<\/jats:italic> promoter methylation could be considered as a potential prognostic marker in tongue carcinoma.<\/jats:p>","DOI":"10.1111\/j.1601-0825.2011.01838.x","type":"journal-article","created":{"date-parts":[[2011,7,13]],"date-time":"2011-07-13T21:44:32Z","timestamp":1310593472000},"page":"794-800","source":"Crossref","is-referenced-by-count":19,"title":["Hypermethylation of <i>RUNX3<\/i> but not <i>WIF1<\/i> gene and its association with stage and nodal status of tongue cancers"],"prefix":"10.1111","volume":"17","author":[{"given":"G","family":"Supic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kozomara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Jovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Zeljic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Magic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-7-94"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi379"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0580"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700547"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06191.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00663.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-008-0508-x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023075"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9821"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0743"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.08.004"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-005-0027-y"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1647"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22967"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0369"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0111"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn017"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.12.220"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411010120020501"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357900701561131"},{"issue":"1","key":"e_1_2_7_22_1","first-page":"S79","article-title":"Towards targeted epigenetic therapy of cancer","volume":"14","author":"Magic Z","year":"2009","journal-title":"J BUON"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1389"},{"key":"e_1_2_7_24_1","first-page":"5954","article-title":"Predicting lung cancer by detecting aberrant promoter methylation in sputum","volume":"60","author":"Palmisano W","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_25_1","first-page":"1035","article-title":"WNT pathway in oral cancer: epigenetic inactivation of WNT\u2010inhibitors","volume":"24","author":"Pannone G","year":"2010","journal-title":"Oncol Rep"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-010-1013-6"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.08.075"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205920"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2010.06.023"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0284"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209739"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208598"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2009.01563.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2005.06.014"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2007.04.015"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2010.07.002"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2009.07.004"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.07.007"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022034510385243"},{"key":"e_1_2_7_40_1","first-page":"4287","article-title":"Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma","volume":"26","author":"Tan SH","year":"2006","journal-title":"Anticancer Res"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.01.009"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2004.05.005"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005892"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1344"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/mp.53.4.165"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1449"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2007.05.011"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.06.015"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.2011.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.2011.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:34:29Z","timestamp":1698752069000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.2011.01838.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.1111\/j.1601-0825.2011.01838.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.2011.01838.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,8]]}}}